Seeking Alpha

The police

The police
Send Message
View as an RSS Feed
View The police's Comments BY TICKER:
Latest  |  Highest rated
  • CAR-T Works, But Dead On Arrival. Inovio's Synthetic DNA Immunotherapy Platform Is About To Transform The Way We Think About Diseases [View instapost]
    You better buy and hold your golden eggs for 2016 hatching.
    Jul 28, 2015. 08:27 PM | Likes Like |Link to Comment
  • Inovio Pharmaceuticals: Small Vaccine Maker Worthy Of Consideration [View article]
    VGX-3100 is going Phase III within a year.
    May 30, 2015. 06:03 PM | 7 Likes Like |Link to Comment
  • Inovio Pharmaceuticals: Small Vaccine Maker Worthy Of Consideration [View article]
    INO will be worth Billions by 2017. Many are about to miss the INO train. As Dr. Kim says, get ready for some shock and awe.

    Just look at brilliant Scientific Advisory Board
    David B. Weiner, Ph.D., Chairman
    Professor, University of Pennsylvania
    Synthetic vaccine pioneer
    Anthony Ford-Hutchinson, Ph.D.
    Former SVP, Merck Vaccines R&D
    Philip D. Greenberg, M.D.
    Head, Program of Immunology, Fred
    Hutchinson Cancer Research Center
    Stanley A. Plotkin, M.D.
    Emeritus Professor, Wistar & UPenn
    Principal Vaxconsult
    May 30, 2015. 05:16 PM | 9 Likes Like |Link to Comment
  • Dendreon Provides A Major Warning To Shareholders [View article]
    Why would they wipe out shareholders. That means all executives and insiders would lose their shares as well. I doubt institutions and the BOD would let this happen. Get real. Buy more.
    Aug 14, 2014. 11:31 PM | 2 Likes Like |Link to Comment
  • Inovio Data Not A Home Run, But Got Company In Great Scoring Position [View article]
    LEEP procedure is not available in 3rd world countries. In USA we are privalaged and have FDA.

    Across the globe they will have Inovio.
    Jul 26, 2014. 10:34 AM | 1 Like Like |Link to Comment
  • Inovio Data Not A Home Run, But Got Company In Great Scoring Position [View article]
    THey dont have leep Around the globe , maybe in America. TIme to think globally. HPV is global... but people will never understand.
    Jul 26, 2014. 10:34 AM | 1 Like Like |Link to Comment
  • Inovio Data Not A Home Run, But Got Company In Great Scoring Position [View article]
    What was the overall clearance. It has to be higher than 40%. 40% in is regression and clearance. What about just clearance. That is Dr. Kims Ace in the hole. Maybe 70% clearance... Without his immures activators.
    Jul 25, 2014. 03:22 PM | 1 Like Like |Link to Comment
  • 3 Convincing Reasons To Buy Dendreon [View article]
    3 weeks out and no CEO successor? That s because there will be a buyout. No new CEO needed.
    Jul 24, 2014. 02:58 PM | 2 Likes Like |Link to Comment
  • Dendreon May Still Be In Play [View article]
    Then it shows that Allergen wants to make a bio similar? It would be cheaper to buy them out than make a bio similar , R&D proprietary methods etc.
    Jun 25, 2014. 01:43 AM | Likes Like |Link to Comment
  • Dendreon May Still Be In Play [View article]
    Why does Allergan own internet domain names for Dendreon products?
    Jun 24, 2014. 09:12 PM | 2 Likes Like |Link to Comment
  • Dendreon: An Update On The Debt Situation [View article]
    Also, Allergan owns domain names for Lapuleucel-T and Sipuleucel-T. Why do think this is true?
    Jun 18, 2014. 03:46 PM | Likes Like |Link to Comment
  • Dendreon: An Update On The Debt Situation [View article]
    Allergan owns domain names for Lapuleucel-T and Sipuleucel-T. Why do this this is true?
    Jun 18, 2014. 01:56 PM | 1 Like Like |Link to Comment
  • Inovio Price Volatility: Market-Naive Moves By Management And Confusion Over Scientific Issues [View article]
    Where else has this been covered. Links / sources please.
    Jun 18, 2014. 01:35 PM | 2 Likes Like |Link to Comment
  • Dendreon CEO Leaves: Buyout Or Bankruptcy? [View article]
    Allergan owns domain names for Lapuleucel-T and Sipuleucel-T... why?
    Jun 12, 2014. 02:43 AM | Likes Like |Link to Comment
  • Dendreon CEO Leaves: Buyout Or Bankruptcy? [View article]
    ITs a fair price for the only approved immunotherapy in the EU and USA. Also there are over 10 ongoing trials. DNDN is not going bankrupt.

    Allergan owns domain names for Lapuleucel-T and Sipuleucel-T... why?

    Oh and NEUVENGE...
    Jun 10, 2014. 09:42 PM | Likes Like |Link to Comment
COMMENTS STATS
29 Comments
56 Likes